Thomas L Janky, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 462 Chapman Rd, Chapman, NE 68827 Phone: 308-986-2600 |
News Archive
In a series of studies in breast cancer patients, researchers at The University of Texas M. D. Anderson Cancer Center have confirmed the presence of "chemobrain" after chemotherapy treatment – but they also discovered that a significant portion of patients have cognitive declines even before chemotherapy.
Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today announced financial results for the first quarter of fiscal year (FY) 2010 ended July 31, 2009. Total revenues for the first quarter of FY 2010 increased 345% to $6,750,000, compared to $1,517,000 for the comparable prior year quarter. This increase was primarily generated from increased government contract revenue and from increased sales by Avid Bioservices, the company's wholly owned contract manufacturing subsidiary.
Atrial Fibrillation (AF) Aware Week aims to raise awareness of an important, yet not well understood heart rhythm disturbance. Taking place from the 23-29 November AF Aware Week increases awareness and understanding of AF amongst the general public. With AF effecting over a million people in the UK it is important that understanding of this condition is improved.
Ardea Biosciences, Inc. has announced that it has successfully completed Phase 1 single-ascending-dose, multiple-ascending-dose, food-effect, and drug-interaction studies of RDEA806, a novel HIV non-nucleoside reverse transcriptase inhibitor (NNRTI), in healthy volunteers.
› Verified 5 days ago